Cargando…
Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.
The value of various prognostic factors in breast cancer patients has been determined in a number of studies. Few reports have been published on the dependence of treatment outcome on histological and immunohistochemical characteristics in the primary tumour in patients with metastatic disease. We s...
Autores principales: | Niskanen, E., Blomqvist, C., Franssila, K., Hietanen, P., Wasenius, V. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228069/ https://www.ncbi.nlm.nih.gov/pubmed/9328152 |
Ejemplares similares
-
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?
por: Hietanen, P., et al.
Publicado: (1995) -
A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.
por: Sjöström, J., et al.
Publicado: (1998) -
p53 and erbB-2 Are Not Associated in Matched Cases of Primary and Metastatic Ovarian Carcinomas
por: Rodríguez-Burford, Cristina, et al.
Publicado: (2003) -
Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
por: Aasland, R., et al.
Publicado: (1988) -
Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.
por: Mehta, R. R., et al.
Publicado: (1995)